ArticleBMJ open gastroenterology2025

Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.

Siddharth Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.